Business Fintech News

Taro to Acquire Alchemee From Galderma

Taro to Acquire Alchemee From Galderma

Galderma and Taro Pharmaceutical Industries Ltd.  (“Taro”) announced they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma. The agreement between Galderma and Taro includes Alchemee’s business and assets around the world, including the Proactiv brand.

Latest Fintech Insights : NICE Nexidia Analytics Bolsters Digital Transformation for Leading Universal Bank

“We are excited to add Proactiv to Taro’s broad portfolio of prescription and over-the- counter dermatology products. We look forward to welcoming the Alchemee team into Taro ”

Proactiv has been used and trusted by millions around the world for more than 25 years. Originally set up as a subscription-based business, Proactiv quickly became a leading U.S. consumer acne brand.

The acquisition is subject to customary closing conditions and any necessary regulatory approvals. Financial terms of the transaction have not been disclosed.

At Alchemee, we aspire to inspire. We are alchemists at heart, harnessing science to create powerful wellness solutions. The combination of alchemy and “me” offers the right mixture of science, expertise, and support that empowers our customers with confidence. Through one-of-a-kind expert-designed formulas and positive guidance, Alchemee provides solutions that are as effective as they are transformative. At Alchemee, we are committed to empowering the world one person at a time. Alchemee.

Browse The Complete News About Fintech : Payfare Announces Intention to File to Commence Normal Course Issuer Bid

Galderma is the world’s largest independent dermatology company, present in approximately 100 countries. Since our inception in 1981, we have been driven by a complete dedication to dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine. Focused on the needs of consumers and patients, we work in partnership with healthcare professionals to ensure superior outcomes. Because we understand that the skin we’re in shapes our life stories, we are advancing dermatology for every skin story.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd.,

Read More About Fintech News : MarketForce Raises $40 Million Series A to Scale Up The Super App For Africa’s Informal Merchants

[To share your insights with us, please write to sghosh@martechseries.com]

Related posts

iCreditWorks Announces Vaibhav Mahajan as Chief Strategy Officer and Head of Capital Markets

PR Newswire

Climate Risk Study Finds Advances In Financial Industry Mitigation Strategies; Concerns Linger on Execution

Fintech News Desk

Digital Asset Raises $120 Million Growth Round to Expand Daml Data Network

Fintech News Desk
1